ToxWipe™-Oral, Oranoxis
The revolutionary design of ToxWipe™-Oral integrates sample collection and testing into one, easy-to-use device. Our proprietary technology allows for results in 3-5 minutes. ToxWipe™-Oral is particularly ideal for on-site and roadside testing. Find one that suits your needs below.
- All In One Design
Collect saliva and read results from the same device. Intuitive to use and no need for shaking, squeezing, or pressing. The ToxWipe™ will give reliable results without puzzling pieces together or positioning restrictions. - Sample Sufficiency Indicator
Take the guesswork out of collecting enough saliva and having to repeat saliva collection steps. The blue sample sufficiency indicator will let the user know when there is enough saliva to render accurate results. - Competitive Performance
Our standard ToxWipe™ cut-offs have been set to meet the demands of law enforcement and workplace settings. Need different cut-offs for your target market? We can customize our products to meet your needs.
TOXWIPE™ 7+
The ToxWipe™-Oral 7+ is a rapid screening device for the detection of multiple drugs of abuse in human saliva with well balanced low cut-offs and options available. AS/NZS 4760:2019 standard compliant.
- Amphetamines: 50 [ng/mL]
- Opiates: 50 [ng/mL]
- Cocaine / Benzoylecgonine: 50 [ng/mL]
- Methamphetamine & Ecstasy (MDMA): 50/100 [ng/mL]
- Oxycodone: 40 [ng/mL]
- Benzodiazepines: 10 [ng/mL]
- Marijuana (parent THC): 15 [ng/mL]
TOXWIPE™ 6+
The ToxWipe™-Oral 6+ is a rapid screening device for the detection of multiple drugs of abuse in human saliva with well balanced low cut-offs and options available. Choose between Benzodiazepines or Phencyclidine versions.
- Amphetamines: 50 [ng/mL]
- Opiates*: 50 [ng/mL]
- Cocaine** / Benzoylecgonine: 50 [ng/mL]
- Methamphetamine & Ecstasy (MDMA): 50/100 [ng/mL]
- Benzodiazepines OR Phencyclidine OR Oxycodone: 10/10/40 [ng/mL]
- Marijuana (parent THC): 15 [ng/mL]
TOXWIPE™ 5+
The ToxWipe™-Oral 5+ is a rapid screening device for the detection of multiple drugs of abuse in human saliva with well balanced low cut-offs and options available.
- Amphetamines: 50 [ng/mL]
- Opiates*: 40 [ng/mL]
- Cocaine** / Benzoylecgonine: 20/25 [ng/mL]
- Methamphetamine & Ecstasy (MDMA): 50/100 [ng/mL]
- Marijuana (parent THC): 15 [ng/mL]
TOXWIPE™ 6
The ToxWipe™-Oral 6 is a rapid screening device for the detection of multiple drugs of abuse in human saliva. Similar to the ToxWipe™-Oral +, but increasing THC cut-off to 25 [ng/mL]. Choose between Benzodiazepines or Phencyclidine versions.
- Amphetamines: 50 [ng/mL]
- Opiates*: 50 [ng/mL]
- Cocaine** / Benzoylecgonine: 50 [ng/mL]
- Methamphetamine & Ecstasy (MDMA): 50/100 [ng/mL]
- Benzodiazepines OR Phencyclidine OR Oxycodone: 10/10/40 [ng/mL]
- Marijuana (parent THC): 25 [ng/mL]
TOXWIPE™ 6S
The ToxWipe™-Oral 6S is a rapid screening device for the detection of multiple drugs of abuse in human saliva. Similar to the ToxWipe™-Oral +, but increasing THC cut-off to 40 [ng/mL]. Choose between Benzodiazepines or Phencyclidine versions.
- Amphetamines: 50 [ng/mL]
- Opiates: 40 [ng/mL]
- Cocaine / Benzoylecgonine: 20 [ng/mL]
- Methamphetamine & Ecstasy (MDMA): 50/100 [ng/mL]
- Benzodiazepines: 10 [ng/mL]
- Marijuana (parent THC): 40 [ng/mL]
TOXWIPE™ 5S
The ToxWipe™-Oral 5S is a rapid screening device for the detection of multiple drugs of abuse in human saliva. Similar to the ToxWipe™-Oral +, but increasing THC cut-off to 40 [ng/mL].
- Amphetamines: 50 [ng/mL]
- Opiates: 40 [ng/mL]
- Cocaine / Benzoylecgonine: 20 [ng/mL]
- Methamphetamine & Ecstasy (MDMA): 50/100 [ng/mL]
- Marijuana (parent THC): 40 [ng/mL]
CUSTOM TOXWIPE™-ORAL
The ToxWipe™ platform can be changed to meet a specific set of target drugs and cut-offs. See the table below for a range of viable cutoffs.
- Amphetamines: 35 – 100 [ng/mL]
- Opiates: 10 – 40 [ng/mL]
- Cocaine / Benzoylecgonine: 15 – 50 [ng/mL]
- Methamphetamine & Ecstasy (MDMA): 35 – 100 [ng/mL]
- Benzodiazepines or Phencyclidine (PCP): 10 – 20 [ng/mL]
- Marijuana (parent THC): 15 – 100 [ng/mL]
Reviews
There are no reviews yet.